Lanzkowsky's Manual of Pediatric Hematology and Oncology

Lymphoproliferative disorders

Lymphoproliferative disorders (LPDs) manifest with uncontrolled hyperplasia of lymphoid tissues (lymph nodes, spleen, bone marrow, liver). They are a heterogeneous group of diseases that range from reactive polyclonal hyperplasia (immunologic disorders) to true monoclonal (malignant) diseases. Angioimmunoblastic lymphadenopathy with dysproteinemia…

Histiocytic disorders

Introduction Langerhans cell histiocytosis and related neoplastic histiocytoses (Erdheim–Chester disease, juvenile xanthogranuloma, and Rosai–Dorfman disease) typically arise from clonal proliferation of myeloid precursor cells driven by pathologically activated MAPK signaling, where hemophagocytic lymphohistiocytosis is a heterogeneous syndrome characterized by excessive…

Vascular anomalies

Introduction When a patient with a suspected vascular anomaly is referred for consultation, it is critical to establish the correct diagnosis. The classification of vascular anomalies from the International Society for the Study of Vascular Anomalies (ISSVA) updated in 2018…

Disorders of coagulation

Hemostatic disorders Physiology of hemostasis As a result of injury to the blood vessel endothelium, three events take place concurrently: 1. vasoconstriction (vascular phase), 2. platelet plug formation (primary hemostatic mechanism—platelet phase), and 3. fibrin thrombus formation (initiation, amplification, and…

Disorders of platelets

Platelets are an important component in primary hemostasis. Defects in platelet number or function may lead to bleeding and bruising. Bleeding due to platelet disorders usually involves skin and mucous membranes, presenting as petechiae, purpura, ecchymosis, epistaxis, hematuria, menorrhagia, as…